Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: New York NY, Baltimore MD, Richmond VA, Aventura FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03606967

Phase 2, Recruiting

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 16+

Code: NCT05269381

Phase 1, Phase 2, Recruiting

Blood Donor CVD 5000

for
Risk Reduction
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT03971669

Recruiting

Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression

for
Depression, Healthy
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: All

Age: 18 - 60

Code: NCT03756246

Recruiting

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

for
Type 1 Diabetes, Kidney Transplant
Location: Philadelphia PA, Toronto, Pittsburgh PA, Madison WI,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 65

Code: NCT06832410

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

for
Metastatic Oropharyngeal Carcinoma,
Location: Birmingham AL, Nashville TN
Sponsor: Michael K. Gibson

Sex: All

Age: 18+

Code: NCT05799144

Phase 2, Recruiting

RSV Vaccine Pregnancy Registry

for
Respiratory Syncytial Virus (RSV)
Location: Wilmington NC
Sponsor: CorEvitas

Sex: Female

Age: 18 - 50

Code: NCT06521944

Recruiting

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

for
Muscle-Invasive Bladder Carcinoma,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06529822

Phase 1, Recruiting

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age

for
Chickenpox
Location: Fall River MA, The Bronx NY, Richmond VA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 1

Code: NCT06740630

Phase 3, Recruiting

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

for
Advanced Fallopian Tube Carcinoma,
Location: Jacksonville FL, Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: Female

Age: 18+

Code: NCT06639074

Phase 2, Recruiting

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

for
Clinical Stage I Cutaneous Melanoma AJCC v8,
Location: Columbus OH
Sponsor: Carlo Contreras

Sex: All

Age: 18 - 70+

Code: NCT04697576

Phase 1, Recruiting

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

for
Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT03501576

Recruiting

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

for
Endometrial Cancer, Cancer of Endometrium,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06253494

Phase 1, Phase 2, Recruiting

A Study of BLB-201 RSV Vaccine in Infants and Children

for
Respiratory Syncytial Virus Infections
Location: Beachwood OH, Greenville SC, Allen Park MI, Atlanta GA,
Sponsor: Blue Lake Biotechnology Inc.

Sex: All

Age: 0 - 5

Code: NCT05655182

Phase 1, Phase 2, Recruiting

COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases

for
Rheumatoid Arthritis, Autoimmune Rheumatologic Disease,
Location: Quebec, Montreal
Sponsor: Paul R Fortin

Sex: All

Age: 18+

Code: NCT05236491

Phase 2, Phase 3, Recruiting

A Trial to Evaluate the Effect of CD388/MK1406 on the Immunogenicity of Fluzone® HD Vaccine (CD388.SQ.1.08/MK-1406-007)

for
Healthy Participants
Location: Hartsdale NY, Baltimore MD, Rochester NY, Miami FL,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 18 - 49

Code: NCT07300085

Phase 1, Recruiting

Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study

for
Decision-Making, Patient Care, Treatment Decisions
Location: Roanoke VA, Fayetteville AR, Albuquerque NM
Sponsor: University of Arkansas, Fayetteville

Sex: All

Age: 18+

Code: NCT07842367

Phase 2, Recruiting

IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy

for
Recurrent Prostate Cancer, Prostate Cancer
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18 - 70+

Code: NCT07686380

Phase 2, Recruiting

A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults

for
Respiratory Syncytial Virus (RSV)
Location: New York NY, Baltimore MD, Washington D.C. DC,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07768345

Phase 3, Recruiting

A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer

for
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Location: Omaha NE
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT05242965

Phase 2, Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial